ТОО "ИНВЕСТ МЕД-1"
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Risks
0/18Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Procurement signals
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses and permits
Summary
Министерство юстиции РКActivities
01450 Разведение овец и коз
Разведение овец и коз
Contacts
Change history
Financial statements
PremiumPublic contracts
What it sells and where
Samruk-Kazyna procurement
Tender bids
Procurement as a customer
Assets
Bank accounts
Leadership
1- АЖ
Акылбекова Жанат Мыйзайбековна
Director
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Company networks
PremiumSimilar companies
Media mentions
Company summary
ТОО "ИНВЕСТ МЕД-1" (BIN 221140026857) is an active legal entity, registered in 2022, located in Abai Region, 4 years on the market. The main line of business is crop and animal production, hunting. Small enterprise, headcount: up to 5 employees. No risk indicators for «ИНВЕСТ МЕД-1» were found in open registries. Date of the last change record: October 1, 2024 (change of main activity). Structure on record: 1 founder. Head per the registry: Акылбекова Жанат Мыйзайбековна. Registry data current as of June 11, 2026.
Data sources and disclaimer
Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.